Therapy of relapsed multiple myeloma

被引：0
|
作者：
Driessen, C. [1 ]
机构：
[1] Kantonsspital St Gallen, Onkol Hamatol, St Gallen, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V68
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Therapy for relapsed multiple myeloma
    Aljama, Mohammed A.
    Sidiqi, M. Hasib
    Dingli, David
    PANMINERVA MEDICA, 2018, 60 (04) : 174 - 184
  • [2] Therapy of relapsed and relapsed refractory multiple myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
  • [3] Therapy of relapsed and relapsed-refractory Multiple Myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 8 - 8
  • [4] Therapy of patients with relapsed Multiple Myeloma
    Gramatzki, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 26 - 26
  • [5] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [6] Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
    Lonial, Sagar
    Dimopoulos, Meletios
    Palumbo, Antonio
    White, Darrell
    Grosicki, Sebastian
    Spicka, Ivan
    Walter-Croneck, Adam
    Moreau, Philippe
    Mateos, Maria-Victoria
    Magen, Hila
    Belch, Andrew
    Reece, Donna
    Beksac, Meral
    Spencer, Andrew
    Oakervee, Heather
    Orlowski, Robert Z.
    Taniwaki, Masafumi
    Roellig, Christoph
    Einsele, Hermann
    Wu, Ka Lung
    Singhal, Anil
    San-Miguel, Jesus
    Matsumoto, Morio
    Katz, Jessica
    Bleickardt, Eric
    Poulart, Valerie
    Anderson, Kenneth C.
    Richardson, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (07): : 621 - 631
  • [7] Evolution of Therapy for Relapsed/Refractory Multiple Myeloma
    Castillo, Jorge J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1433 - 1436
  • [8] Carfilzomib boosted combination therapy for relapsed multiple myeloma
    Steiner, Raphael E.
    Manasanch, Elisabet E.
    ONCOTARGETS AND THERAPY, 2017, 10 : 895 - 907
  • [9] VENETOCLAX AS TARGETED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    HAEMATOLOGICA, 2017, 102 : 268 - 269
  • [10] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
12345